via University College London
An artificial intelligence (AI) algorithm that can detect subtle brain abnormalities which cause epileptic seizures has been developed by a UCL-led team of international researchers.
The Multicentre Epilepsy Lesion Detection project (MELD) used over 1,000 patient MRI scans from 22 global epilepsy centres to develop the algorithm, which provides reports of where abnormalities are in cases of drug-resistant focal cortical dysplasia (FCD) – a leading cause of epilepsy.
FCDs are areas of the brain that have developed abnormally and often cause drug-resistant epilepsy. It is typically treated with surgery, however identifying the lesions from an MRI is an ongoing challenge for clinicians, as MRI scans in FCDs can look normal.
To develop the algorithm, the team quantified cortical features from the MRI scans, such as how thick or folded the cortex/brain surface was, and used around 300,000 locations across the brain.
Researchers then trained the algorithm on examples labelled by expert radiologists as either being a healthy brain or having FCD – dependant on their patterns and features.
The findings, published in Brain, found that overall the algorithm was able to detect the FCD in 67% of cases in the cohort (538 participants).
Previously, 178 of the participants had been considered MRI negative, which means that radiologists had been unable to find the abnormality – yet the MELD algorithm was able to identify the FCD in 63% of these cases.
This is particularly important, as if doctors can find the abnormality in the brain scan, then surgery to remove it can provide a cure.
Co-first author, Mathilde Ripart (UCL Great Ormond Street Institute of Child Health) said: “We put an emphasis on creating an AI algorithm that was interpretable and could help doctors make decisions. Showing doctors how the MELD algorithm made its predictions was an essential part of that process.”
Co-senior author, Dr Konrad Wagstyl (UCL Queen Square Institute of Neurology) added: “This algorithm could help to find more of these hidden lesions in children and adults with epilepsy, and enable more patients with epilepsy to be considered for brain surgery that could cure the epilepsy and improve their cognitive development. Roughly 440 children per year could benefit from epilepsy surgery in England.”
Around 1% of the world’s population have the serious neurological condition epilepsy, that is characterised by frequent seizures.
In the UK some 600,000 people are affected. While drugs treatments are available for the majority of people with epilepsy, 20-30% do not respond to medications.
In children who have had surgery to control their epilepsy, FCD is the most common cause, and in adults it is the third most common cause.
Additionally, of patients who have epilepsy that have an abnormality in the brain that cannot be found on MRI scans, FCD is the most common cause.
Co-first author, Dr. Hannah Spitzer (Helmholtz Munich) said: “Our algorithm automatically learns to detect lesions from thousands of MRI scans of patients. It can reliably detect lesions of different types, shapes and sizes, and even many of those lesions that were previously missed by radiologists.”
Co-senior author, Dr Sophie Adler (UCL Great Ormond Street Institute of Child Health) added: “We hope that this technology will help to identify epilepsy-causing abnormalities that are currently being missed. Ultimately it could enable more people with epilepsy to have potentially curative brain surgery.”
This study on FCD detection uses the largest MRI cohort of FCDs to date, meaning it is able to detect all types of FCD.
The MELD FCD classifier tool can be run on any patient with a suspicion of having an FCD who is over the age of 3 years and has an MRI scan.
The MELD project is supported by the Rosetrees Trust.
Different MRI scanners were used at the 22 hospitals involved in the study around the globe, which enables the algorithm to be more robust but might also affect algorithm sensitivity and specificity.
Original Article: AI algorithm that detects brain abnormalities could help cure epilepsy
More from: University College London
The Latest Updates from Bing News
Go deeper with Bing News on:
- ‘Dinner for a Cause’ to benefit Epilepsy Foundation of Washington will be Thursday night, Dec. 21 at Burien Elks
Over 75,000 people in Washington State are living with epilepsy, and here's how YOU can help. Attend the "Dinner for a Cause" benefitting the Epilepsy Foundation of Washington at the Burien Elks Lodge ...
- Diversity in Disability brings awareness to epilepsy
Every month, the NMU student organization Diversity in Disability chooses a disability to shine a light on to spread awareness. On Dec. 9 at 10 a.m. Diversity in Disability is hosting an epilepsy ...
- Eye On Health: ROSA robot helping patients with epilepsy
PTL's Katie O'Malley visits AHN's Department of Neurosurgery to get a look at a new robot tool named ROSA that is helping patients dealing with epilepsy.
- This Cyclist Just Finished an Ironman, Showing She Won’t Let Epilepsy Slow Her Down
While cyclist Annie Brooks still has seizures due to epilepsy, she is able to train and compete in triathlons.
- Spotting Epilepsy in Kids Isn't Always Easy: Know the Signs
If epilepsy is diagnosed, the condition can often be managed with medications. Tests are pinpointing the genes that drive epilepsy, and in some cases genetic testing can help doctors decide which ...
Go deeper with Bing News on:
- Genetic Testing Warranted in Epilepsy of Unknown Origin
Benefits of genetic testing in adults with unexplained epilepsy include enrollment in a clinical trial of a relevant gene therapy, connection to families with a similar diagnosis, and peace of mind.
- TRV-045 by Trevena for Epilepsy: Likelihood of Approval
TRV-045 is under development for the treatment of chemotherapy-induced peripheral neuropathy, diabetic neuropathic pain, chronic pain, inflammatory pain and epilepsy. The drug candidate is a new ...
- New model enhances precision in seizure localization for epilepsy patients
A research team led by Prof. Zhan Yang from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences, has recently introduced a novel unsupervised dual-stream model ...
- Autism cure in sight as Chinese scientists reach milestone in mice testing
Autism is characterised by difficulty connecting and communicating with others, as well as repeated habits and intense interests caused by MEF2C mutations ...
- Xenon stock surges as B.C. biotech’s epilepsy drug shows promise for treating depression
Company co-founded by renowned geneticist Michael Hayden building franchise around treatment discovered by Valeant ...